Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency

被引:26
作者
Achouitar, Samira [2 ]
Goldstein, Jennifer L. [1 ]
Mohamed, Miski [1 ]
Austin, Stephanie [2 ]
Boyette, Keri [2 ]
Blanpain, Francoise M. [3 ]
Rehder, Catherine W. [3 ]
Kishnani, Priya S. [2 ]
Wortmann, Saskia B. [1 ]
den Heijer, Martin [4 ]
Lefeber, Dirk J. [5 ,6 ]
Wevers, Ron A. [6 ]
Bali, Deeksha S. [1 ,2 ]
Morava, Eva [1 ]
机构
[1] Duke Univ, Div Med Genet, Dept Pediat, Med Ctr, Durham, NC 27510 USA
[2] Radboud Univ Nijmegen, Dept Pediat, Inst Genet & Metab Dis, Med Ctr, Nijmegen, Netherlands
[3] Duke Univ, Dept Pathol, Med Ctr, Durham, NC 27510 USA
[4] Radboud Univ Nijmegen, Dept Endocrinol, Inst Genet & Metab Dis, Med Ctr, Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Dept Neurol, Inst Genet & Metab Dis, Med Ctr, Nijmegen, Netherlands
[6] Radboud Univ Nijmegen, Lab Genet Metab & Endocrine Dis, Inst Genet & Metab Dis, Med Ctr, Nijmegen, Netherlands
关键词
Hypoglycemia; Tube-feeding; Diarrhea; Founder effect; Glycogen storage disease type IX; CLINICAL PHENOTYPE; ALPHA-SUBUNIT; GLYCOGENOSIS; VARIABILITY;
D O I
10.1016/j.ymgme.2011.08.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We found that the missense mutation p.Pro1205Leu in the PHKA2 gene is a common cause of hepatic phosphorylase-kinase deficiency in Dutch patients, suggesting a founder-effect. Most patients presented with isolated growth delay and diarrhea, prior to the occurrence of hepatomegaly, delaying diagnosis. Tetra-glucoside excretion correlated with disease severity and was used to follow compliance. The clinical presentation and therapeutic requirements in the same mutation carriers were variable, and PhK deficiency necessitated tube-feeding in some children. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:691 / 694
页数:4
相关论文
共 11 条
[1]   Glycogen storage disease type IX: High variability in clinical phenotype [J].
Beauchamp, Nicholas James ;
Dalton, Ann ;
Ramaswami, Uma ;
Nimikoski, Harri ;
Mention, Karine ;
Kenny, Patricio ;
Kolho, Kaija-Leena ;
Raiman, Julian ;
Walter, John ;
Treacy, Eileen ;
Tanner, Stuart ;
Sharrard, Mark .
MOLECULAR GENETICS AND METABOLISM, 2007, 92 (1-2) :88-99
[2]   Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene [J].
Burwinkel, B ;
Amat, L ;
Gray, RGF ;
Matsuo, N ;
Muroya, K ;
Narisawa, K ;
Sokol, RJ ;
Vilaseca, MA ;
Kilimann, MW .
HUMAN GENETICS, 1998, 102 (04) :423-429
[3]   Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene [J].
Burwinkel, B ;
Rootwelt, T ;
Kvittingen, EA ;
Chakraborty, PK ;
Kilimann, MW .
PEDIATRIC RESEARCH, 2003, 54 (06) :834-839
[4]   3D mapping of glycogenosis-causing mutations in the large regulatory alpha subunit of phosphorylase kinase [J].
Carriere, Cathelene ;
Jonic, Slavica ;
Mornon, Jean-Paul ;
Callebaut, Isabelle .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2008, 1782 (11) :664-670
[5]  
Goldstein J., 2011, GENEREVIEWS GENETEST
[6]   Complete genomic structure and mutational spectrum of PHKA2 in patients with X-linked liver glycogenosis type I and II [J].
Hendrickx, J ;
Lee, P ;
Keating, JP ;
Carton, D ;
Sardharwalla, EB ;
Tuchman, M ;
Baussan, C ;
Willems, PJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) :1541-1549
[7]   Mutational analyses in four Japanese families with X-linked liver phosphorylase kinase deficiency type 1 [J].
Hirono, H ;
Shoji, Y ;
Takahashi, T ;
Sato, W ;
Takeda, E ;
Nishijo, T ;
Kuroda, Y ;
Nishigaki, T ;
Inui, K ;
Takada, G .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (08) :846-852
[8]  
Kishnani P., 2009, SCRIVERS ONLINE META
[9]   Biochemical characteristics and increased tetraglucoside excretion in patients with phosphorylase kinase deficiency [J].
Morava, E ;
Wortmann, SB ;
van Essen, HZ ;
van Sambeek, RL ;
Wevers, R ;
van Diggelen, OP .
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (05) :703-706
[10]  
VANDENBERG IET, 1995, AM J HUM GENET, V56, P381